Studies have indicated that the excessive release of pro-inflammatory factors could lead to neuronal apoptosis dependent on caspase-3 pathway activation, and the application of zDVED-FMK (a caspase-3-specific inhibitor) can decrease neuronal apoptosis induced by cerebral ischemia‒reperfusion injury [48–50]. This evidence concerns the gene CASP3 and brain ischemia.